Abstract -Bioactivity-guided fractionation of a methanolic extract of Buddleja officinalis led to the isolation of two monoterpenes, crocusatin M (1), crocusatin C (2), a flavonoid, acacetin (3), three lignans, lariciresinol (4), pinoresinol (5), and syringaresinol (6), and two triterpenoidal saponins, mimengoside B (7) and songarosaponin A (8). The structures of isolates were identified based on 1D-, 2D-NMR, and MS data analysis. All isolates were tested for their inhibition on LPS-induced NO production in RAW 264.7 cells. As a result, mimengoside B (7) and songarosaponin A (8) showed a mild inhibitory activity of NO production.
Introduction
Buddleja officinalis Maxim. (Buddlejaceae), a shrub tree, has been widely distributed in temperate regions of America, Africa, and Asia. The flower buds of B. officinalis have been used in traditional Korean medicine for the treatment of stroke, headache, neurological disorders, conjunctivitis, and other ophthalmologic diseases.
1 Previous phytochemical investigations on B. officinalis have reported to contain several types of compounds such as terpenoids, flavonoids, iridoids, phenylethanoids, and saponins. [1] [2] [3] [4] [5] [6] [7] In the course of an investigation for the isolation of plantderived nitric oxide (NO) production inhibitors, a MeOH extract of the flower buds of B. officinalis showed inhibitory effects on LPS-induced NO production. The dried flower buds of B. officinalis were extracted with MeOH, and the resultant extract was partitioned successively with n-hexane, CH 2 Cl 2 , and water. Using various types of column chromatography and preparative HPLC, two monoterpenes, a flavonoid, three lignans, and two triterpenoidal saponins were isolated from the CH 2 Cl 2 soluble fraction. Their structures were identified based on 1D-, 2D-NMR, and MS data analysis, as well as by comparison with previously reported spectroscopic data. This paper herein deals with the isolation and structure elucidation of the isolated compounds, and their inhibitory effects on LPS-induced NO production in RAW 264.7 cells.
Experimental
General experimental procedures -UV spectra were obtained using a JASCO UV-550. NMR spectra were recorded on a Bruker AMX-500 MHz NMR spectrometer. ESIMS was performed on a Waters Q-TOF micro mass spectrometer. Open column chromatography and MPLC were performed using a silica gel (Kiesel gel 60, 700 -230 mesh, Merck) and a LiChroprep RP-18 (40 -60 μM, Merck), respectively. Preparative HPLC was conducted using a Waters system (515 pump and 2996 photodiode array detector) with a YMC J'sphere ODS-H80 column (4 μm, 20 × 250 mm, i.d., flow rate 6 mL/min). Thin layer chromatography (TLC) was performed using pre-coated silica gel 60 F254 plates (0.25 mm, Merck).
Plant Measurement of LPS-induced NO production and cell viability -Griess reaction was used to determine the nitrite concentration in the medium as an indicator of NO production. Briefly, RAW 264.7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and penicillin (100 units/mL)-streptomycin (100 μg/mL) in an incubator at 37 o C and 5% CO 2 . RAW 264.7 cells were seeded into 96 well culture plates at 2 × 10 6 cells/mL and treated with 1 μg/mL of LPS in the presence or absence of compounds. After incubation of 24 h, 100 μL of cellfree supernatant was mixed with 100 μL of Griess reagent containing equal volumes of 2% (w/v) sulfanilamide in 5% (w/v) phosphoric acid and 0.2% (w/v) N-(1-naphthyl) ethylenediamine solution to determine nitrite production. Cell viability of the remaining cells was determined by a cell counting kit (CCK) (Dojindo, Kumamoto, Japan) based colorimetric assay.
Result and Discussion
Eight known compounds 1 -8 were isolated from the CH 2 Cl 2 soluble fraction of the flower buds of B. officinalis by repeated chromatographic separation including silica gel, RP-18, and preparative HPLC. Their structures were identified as crocusatin M (1), 8 crocusatin C (2), 9 acacetin (3), 10 lariciresinol (4), 11 pinoresinol (5), 11 syringaresinol (6), 12 mimengoside B (7), 13, 14 and songarosaponin A (8)
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( Fig. 1 ) by comparing their physicochemical and spectroscopic data with those of published data. NO, produced from L-arginine by nitric oxide synthase, is involved in various biological actions such as hostdefense and regulatory molecule for homeostatic equilibrium. However, NO produced by iNOS in macrophages plays an important role in the inflammatory process, and an inhibitor of NO production may have potential therapeutic value as an anti-inflammatory agent. Therefore, compounds 1 -8 isolated from B. officinalis were examined for their inhibitory effects on NO production induced by LPS in RAW 264.7 macrophage cells using the Griess reagent. Aminoguanidine was used as positive control (IC 50 17.5 μM) ( Table 2 ). Cell viability was evaluated by CCK assay, indicating that all compounds did not show any significant cytotoxic activity under tested concentration (cell viability > 90%). Among the isolated compounds, compounds 7 and 8 exhibited inhibitory effects against LPS-induced NO production in a concentration-dependent manner with IC 50 values of 22.1 and 25.6 μM, respectively.
Several triterpenoidal saponins were previously examined also for their inhibitory effects on NO production in RAW 264.7 cells. The inhibitory effects on LPS-induced NO production in RAW 264.7 macrophages were reported for 
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Natural Product Sciences buddlejasaponin IV and songarosaponin D isolated from Physospermum verticillatum. 16 Buddlejasaponin IV isolated from Pleurospermum kamtschatidum showed inhibitory effects on NO, PGE 2 , and TNF-α production by suppression of the expressions of iNOS, COX-2, TNF-α, IL-1β and IL-6 through blocking of NF-κB activation.
17,18
Recently, it has been reported that the water extract of B. officinalis inhibited LPS-induced NO release, and iNOS, IL-1β, and IL-6 expression, by the regulation of ERK 1/2 and NF-κB signaling pathways in BV-2 cells.
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In conclusion, our findings and previously reported data may support that triterpenoidal saponins, mimengoside B (7) and songarosaponin A (8), from B. officinalis could be considered as possible anti-inflammatory compounds for further investigation. 
